Sexually transmitted infection rates in Cotonou
| GC* | CT* | TV† | Candida† | HSV-2‡ | Syphilis§ | Genital ulcer¶ | |
|---|---|---|---|---|---|---|---|
| *NG/CT Amplicor PCR on urethral or cervical swabs unless otherwise specified; †direct microscopy unless otherwise specified; ‡serum ELISA; §RPR + TPHA positive; ¶clinical examination; **NG/CT Amplicor PCR on urine with LCR confirmation; ††culture; ‡‡EIA on cervical swabs; §§NG/CT Amplicor PCR on urine; ¶¶”in house” PCR. | |||||||
| CT, chlamydia trachomatis; FSW, female sex worker; GC, Neisseria gonorrhoea; PCR, polymerase chain reaction; STI, sexually transmitted infection; TV, Trichomonas vaginalis. | |||||||
| General population men 15–49 years; n=928 | 1.1%** | 2.3%** | – | – | 11.9% | 1.8% | 6.4% |
| General population women 15–49 years; 97–98; n=1015 | 0.9%** | 1.3%** | 3.2%†† | – | 29.5% | 1.2% | – |
| Pregnant women 1993 (SIDA2; n=403) | 2.0%†† | 2.7%‡‡ | 17.0% | 34.4% | – | 2.2% | 9.4% |
| STI clinic men urethral discharge 1993 (SIDA2; n=128) | 39.0% | 7.6% | – | – | – | 4.8% | 3.7% |
| STI clinic women vaginal discharge1993 (SIDA2; n=211) | 5.7% | 2.1% | 11.5% | 32.3% | – | 2.1% | 9.9% |
| FSW 1993 (SIDA2; n=374) | 43% | 9% | 8.8% | 16.0% | – | 9.1% | 16.8% |
| FSW 1995–6 (SIDA2; n=350) | 31% | 7% | 12% | 23% | – | 7% | – |
| FSW 1998–9 (SIDA2; n=590) | 21% | 4% | 9% | 9% | – | 2% | – |
| Clients of FSW 1998 (SIDA2; n=404) | 5.4%§§ | 2.7%§§ | 2.7%¶¶ | – | – | – | 2.0% |
| Boyfriends of FSW (SIDA2; n=56) | 5.4%§§ | 1.8%§§ | 5.4%¶¶ | – | – | – | 1.8% |